<DOC>
	<DOCNO>NCT00311350</DOCNO>
	<brief_summary>This first multiple-dose experience human MOA-728 oral formulation . This study provide assessment safety , tolerability , pharmacokinetics ( PK ) MOA-728 follow administration ascend multiple oral dos healthy subject .</brief_summary>
	<brief_title>Study Evaluating Safety MOA-728 Administered Orally Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<criteria>Healthy men woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Safety</keyword>
	<keyword>Health</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>ileus</keyword>
</DOC>